“Generic AI tools struggle with ABL due to limited training data and lack of domain context,” said John Ainsworth, EVP and General Manager, Application and Data Platform, Progress Software. “The ...
Immunovant, Inc. reported significant progress related to its lead asset IMVT-1402, having secured six Investigational New Drug applications and currently enrolling participants in pivotal studies for ...
A 'Hold' Rating for Shares of i-80 Gold Corp. This analysis recommends a “Hold” rating on the publicly traded shares of i-80 Gold Corp. (IAU:CA). About its own profile, i-80 Gold Corp. says: “i-80 ...
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results